Experimental Mouse Resources Core
实验鼠标资源核心
基本信息
- 批准号:10681258
- 负责人:
- 金额:$ 22.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-01 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AMD3100AcclimatizationAdultAirAnimalsBiologyBone MarrowBone Marrow TransplantationBreedingCSF3 geneCell Culture TechniquesCell physiologyCellsChimerismClinicalCollecting CellCommunitiesCongenic MiceConsultationsCytometryData AnalysesDedicationsDoseEnsureExperimental DesignsFacultyFundingFutureGoalsGranulocyte-Macrophage Colony-Stimulating FactorGrowth FactorHarvestHematologyHematopoiesisHematopoieticHematopoietic stem cellsHumanHuman ResourcesHypoxiaIL3 GeneImmuneImmunodeficient MouseIndividualInfrastructureInvestigationLaboratoriesMedical StudentsMethodologyMolecularMouse StrainsMusNon-MalignantProceduresProcessProductionRegulationResearchResearch ActivityResearch InfrastructureResearch PersonnelResearch Project GrantsResearch SupportResourcesSamplingScientistServicesSiteTechnical ExpertiseTherapeuticTimeTissue TransplantationTissuesTrainingTraining ActivityTransgenic OrganismsTransplantationUmbilical Cord BloodWorkboyscareercell typeclinical efficacycongeniccostdesigneducation resourcesexperimental studygraduate studentin vivoirradiationmembernext generationperipheral bloodpreventstem cell biologystem cell functiontransplant model
项目摘要
The Cooperative Centers of Excellence in Hematology (CCEH) will be utilized by investigators for in vivo
studies focused on molecular and cellular mechanisms involved in steady state hematopoiesis, the bone
marrow niche, BM transplantation, and immune cell function. Centralization will prevent duplication of
resources, ensure consistent supply of acclimated mice, and maintain high quality research infrastructure
essential for conducting in vivo studies of hematopoietic stem and progenitor cell (HSPC) function. The
Experimental Mouse Resources Core (EMRC) will provide CCEH investigators advanced resources for their
studies using mice for murine and human transplantation models. The specific aims of the EMRC are:
1. Maintain on-site breeding colonies of essential mice to study human and murine hematopoiesis in
vivo. For investigations focused on human hematopoiesis, colonies of NOD.Cg-PrkdcscidIl2rgtm1Wjl/J (NSG)
and NOD.Cg-Ragtm1MomIl2rgtm1Wjl/SzJ and (NRG) immunodeficient mice will be maintained. In anticipation of
future needs, a starter colony of the triple transgenic NSG-SGM3 (NSGS) mice that express human IL3,
GM-CSF and SCF has been established and can be expanded as needed. Breeding colonies of
C57/BL/6J, B6.SJL-Ptprca Pepcb/BoyJ (Boy/J), and the BoyJ x C57BL/6J (F1 cross) mouse strains will be
maintained. The F1 cross is a unique strain and is not commercially available. Congenic mouse strains
allow for simultaneous tracking of donor, competitor, and recipient cells.
2. Provide specialized core services and consultation to CCEH investigators. EMRC personnel will
conduct irradiations, transplantations, serial sampling of peripheral blood, and compound dosing. The Core
will harvest and provide tissues from transplanted mice to investigators for detailed analysis by the CCEH
Flow and Tissue Cytometry Core. The ERMC will work closely with the Hypoxia Core to coordinate
transplant of mouse and human HSPC collected and processed under hypoxia versus ambient air (Mantel
et al., Cell 2015). The EMRC Director will coordinate with Core personnel all procedures, experimental
design, methodology, and data interpretation. Expertise and infrastructure is in place to facilitate all aspects
of BMT studies seamlessly for on-site CCEH members as well as PIs on a national level.
3. Serve as an educational resource for CCEH laboratories. Exceptional connectivity between the EMRC
and the other biomedical cores as well as the Enrichment core will augment the research and training
activities of the CCEH membership and their trainees. Training in the execution of high-quality in vivo
studies will be a critical and essential component in training our next generation of scientists to be
successful in research careers dedicated to the study of nonmalignant hematology.
4. Work in concert with other CCEH centers and investigators Nationwide to provide EMRC services to
the community of scientists involved in nonmalignant hematology research.
研究者将利用血液学卓越合作中心(CCEH)进行体内研究。
研究集中在稳态造血、骨生成、骨再生、骨
骨髓生态位、骨髓移植和免疫细胞功能。集中化将防止重复
资源,确保驯化小鼠的持续供应,并保持高质量的研究基础设施
这对于进行造血干细胞和祖细胞(HSPC)功能的体内研究至关重要。的
实验小鼠资源核心(EMRC)将为CCEH研究人员提供先进的资源,
使用小鼠作为鼠和人移植模型的研究。该公司的具体目标是:
1.维持基本小鼠的现场繁殖集落,以研究人类和小鼠的造血,
vivo.对于关注人造血的研究,NOD. Cg-PrkdcscidIl 2 rgtm 1 Wjl/J(NSG)的菌落
和NOD. Cg-Ragtm 1 MomI 12 rgtm 1 Wjl/SzJ和(NRG)免疫缺陷小鼠。由于预期
未来需要,表达人IL 3的三重转基因NSG-SGM 3(NSGS)小鼠的起始集落,
GM-CSF和SCF已经建立,并可根据需要扩大。繁殖群体
C57/BL/6 J、B6.SJL-Ptprca Pepcb/BoyJ(Boy/J)和BoyJ x C57 BL/6 J(F1杂交)小鼠品系将
树立政治意识F1杂交是一种独特的菌株,没有市售。同类系小鼠
允许同时追踪供体、竞争者和受体细胞。
2.为CCEH调查员提供专业的核心服务和咨询。机电工程管理局人员会
进行辐照、移植、外周血系列采样和化合物给药。核心
将采集移植小鼠的组织并提供给研究人员,供CCEH进行详细分析
流式细胞术和组织细胞术核心。ERMC将与低氧核心密切合作,
在低氧与环境空气下收集和处理的小鼠和人HSPC移植物(Mantel
例如,Cell 2015)。EMRC主任将与核心人员协调所有程序、实验
设计、方法和数据解释。专业知识和基础设施到位,以促进所有方面
为现场CCEH成员以及国家层面的PI提供无缝的BMT研究。
3.作为CCEH实验室的教育资源。与EMRC之间的卓越连接
其他生物医学核心以及浓缩核心将加强研究和培训
CCEH会员及其学员的活动。在执行高品质的培训在体内
研究将是培养我们下一代科学家的关键和必要组成部分,
在致力于非恶性血液学研究的研究事业中取得成功。
4.与全国其他CCEH中心和调查人员合作,为以下人员提供EMRC服务:
参与非恶性血液学研究的科学家团体。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Karen Elizabeth Pollok其他文献
Karen Elizabeth Pollok的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Karen Elizabeth Pollok', 18)}}的其他基金
Dual Targeting of DNA Repair and p53 pathways for treatment of brain cancer
DNA 修复和 p53 通路双重靶向治疗脑癌
- 批准号:
7986836 - 财政年份:2010
- 资助金额:
$ 22.74万 - 项目类别:
Dual Targeting of DNA Repair and p53 pathways for treatment of brain cancer
DNA 修复和 p53 通路双重靶向治疗脑癌
- 批准号:
8110715 - 财政年份:2010
- 资助金额:
$ 22.74万 - 项目类别:
Dual Targeting of DNA Repair and p53 pathways for treatment of brain cancer
DNA 修复和 p53 通路双重靶向治疗脑癌
- 批准号:
8473057 - 财政年份:2010
- 资助金额:
$ 22.74万 - 项目类别:
Dual Targeting of DNA Repair and p53 pathways for treatment of brain cancer
DNA 修复和 p53 通路双重靶向治疗脑癌
- 批准号:
8676458 - 财政年份:2010
- 资助金额:
$ 22.74万 - 项目类别:
相似海外基金
Mechanisms of acclimatization responses of fetal and adult cerebral artery alpha1 adrenergic receptor subtypes to long-term hypoxia
胎儿和成人脑动脉α1肾上腺素能受体亚型对长期缺氧的适应反应机制
- 批准号:
9072344 - 财政年份:2016
- 资助金额:
$ 22.74万 - 项目类别:
(INTRODUCTION) MECHANISMS OF ACCLIMATIZATION: FETUS AND ADULT
(简介)适应机制:胎儿和成人
- 批准号:
8704962 - 财政年份:1997
- 资助金额:
$ 22.74万 - 项目类别:
(INTRODUCTION) MECHANISMS OF ACCLIMATIZATION: FETUS AND ADULT
(简介)适应机制:胎儿和成人
- 批准号:
8327785 - 财政年份:1997
- 资助金额:
$ 22.74万 - 项目类别:
(INTRODUCTION) MECHANISMS OF ACCLIMATIZATION: FETUS AND ADULT
(简介)适应机制:胎儿和成人
- 批准号:
8117588 - 财政年份:1997
- 资助金额:
$ 22.74万 - 项目类别:
(INTRODUCTION) MECHANISMS OF ACCLIMATIZATION: FETUS AND ADULT
(简介)适应机制:胎儿和成人
- 批准号:
8516067 - 财政年份:1997
- 资助金额:
$ 22.74万 - 项目类别:














{{item.name}}会员




